Funder
National Institutes of Health
National Cancer Institute
National Institute of Allergy and Infectious Diseases
Subject
General Medicine,Immunology,Immunology and Allergy
Reference46 articles.
1. Cancer statistics, 2022;Siegel;CA Cancer J. Clin.,2022
2. PD-1/PD-L1 pathway inhibitors in advanced prostate cancer;Isaacsson Velho;Exp. Rev. Clin. Pharmacol.,2018
3. Immunotherapy of Prostate Cancer: Facts and Hopes;Bilusic;Clin Cancer Res.,2017
4. Prostate cancer immunotherapy: a review of recent advancements with novel treatment methods and efficacy;Wang;Am. J. Clin. Exp. Urol.,2022
5. Passive-specific immunotherapy with monoclonal antibodies for prostate cancer: A systematic review;Khalili;J. Oncol. Pharm. Pract.,2019